Status:
COMPLETED
Exploring Racial Disparities in Sleep Health and Neurocognitive Function
Lead Sponsor:
University of Alabama, Tuscaloosa
Collaborating Sponsors:
UAB Resource Centers for Minority Aging Research (RCMAR)
Conditions:
HIV Dementia
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Despite longer life expectancies due to combination antiretroviral therapy (cART), the prevalence of HIV-associated neurocognitive disorders (HAND) persists thus affecting 52% of the HIV population. P...
Detailed Description
This study is designed with two aims: Aim 1a: To explore differences in sleep health between older HIV+ AA and Whites. 1b: To explore differences in domain-specific neurocognitive impairments between ...
Eligibility Criteria
Inclusion
- HIV+
- Identify as AA or White
- 50 years old or older
- Speak English
Exclusion
- Alzheimer's disease or dementia
- Severe neurocognitive impairment (\>7 errors on the Short Portable Mental Status Questionnaire)
- Deaf or blind
- Currently undergoing radiation/chemotherapy
- Brain trauma with loss of consciousness greater than 30 minutes
- A learning disability
- Significant neuromedical comorbidities (e.g., schizophrenia)
- Currently taking Efavirenz
- Moderate to severe sleep apnea
- Restless leg syndrome
- Narcolepsy
- Left handedness
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04015830
Start Date
January 1 2021
End Date
January 1 2023
Last Update
May 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama
Tuscaloosa, Alabama, United States, 35401